Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Next Pharmaceuticals, Kelatron Sign Supply Agreement - Nutraceuticals World

What are you searching for?

Sign in
Market Updates

Next Pharmaceuticals, Kelatron Sign Supply Agreement

Author Image

By: Sean Moloughney

Editor, Nutraceuticals World

Next Pharmaceuticals, Carlsbad, CA, has signed an exclusive supply agreement with Kelatron, Ogden, UT, for access to its patented Chromulin (U.S. Patent No. 6,689,383) product, which is a water-soluble, bioavailable form of chromium that is ideal for beverage applications and foods targeting any aspect of carbohydrate, protein and fat metabolism. Chromulin features a natural combination of the essential mineral chromium III and the essential amino acid histidine, which was formulated and patented by Dr. Richard Anderson at the USDA.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters